Developing novel drugs for medulloblastoma
This research focuses on the development of novel drugs for the treatment of childhood brain tumours.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
This research focuses on the development of novel drugs for the treatment of childhood brain tumours.
Osteosarcoma bone cancer affects teenagers, around half of whom die within 5-years of diagnosis. We think we can solve these problems by modifying immune cells called “gamma-delta T-cells”.
Examining whether a group of drugs called gliflozins could be used to treat T-ALL
Developing and delivering small molecule drug and immunotherapy combinations for MYC-driven medulloblastoma: Efficacy, evolution and exploitation.
An open label, single centre, single arm, prospective feasibility study evaluating the effectiveness of near-infrared fluorescence(NIRF)using indo-cyanine green(ICG)in intra-abdominal or intra-thoracic minimally invasive surgery(MIS)in paediatric oncology.
Investigating the preclinical efficacy of albendazole in paediatric acute myeloid leukaemia
Repurposing antihistamines to reduce treatment-related toxicity for children with WNT-medulloblastoma
Investigating repurposed drugs to decrease the progression of Ewing’s sarcoma
Enhancing CAR T-cell expansion and prolonged persistence for the effective treatment of paediatric medulloblastoma